Q4 2024 Holdings
Filed 2025-02-14 | 39 holdings | $99.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $9.5M | 1,111,071 | 9.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $7.2M | 104,800 | 7.3% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $7.1M | 351,842 | 7.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $6.3M | 122,900 | 6.3% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $6.0M | 267,368 | 6.1% |
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $5.8M | 1,849,402 | 5.9% |
| Praxis Precision Medicines I(PRAX) | COM | 74006W207 | $5.2M | 67,500 | 5.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $4.9M | 111,700 | 4.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.2M | 6,910 | 4.3% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $3.7M | 45,000 | 3.7% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $3.2M | 771,958 | 3.2% |
| Ascendis PHA(ASND) | SPONSORED ADR | 04351P101 | $3.2M | 22,976 | 3.2% |
| Mereo Biopharma Group PL(MREO) | SPON ADS | 589492107 | $2.7M | 779,308 | 2.7% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $2.5M | 69,124 | 2.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $2.5M | 447,500 | 2.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $2.3M | 87,658 | 2.4% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $1.9M | 180,945 | 1.9% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $1.8M | 2,303,000 | 1.8% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $1.7M | 134,500 | 1.7% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $1.6M | 137,709 | 1.6% |
| Mersana Therapeutics Inc | COM | 59045L106 | $1.6M | 1,120,500 | 1.6% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $1.5M | 884,244 | 1.5% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $1.5M | 33,008 | 1.5% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $1.5M | 54,473 | 1.5% |
| Newamsterdam Pharma Co NV(NAMS) | ORDINARY SHARES | N62509109 | $1.3M | 50,000 | 1.3% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $984.4K | 67,240 | 1.0% |
| Eledon Pharmaceuticals Inc(ELDN) | #N/A | 28617K101 | $971.3K | 235,750 | 1.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $903.5K | 160,200 | 0.9% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $883.5K | 21,000 | 0.9% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $845.2K | 9,150 | 0.9% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $823.9K | 10,743 | 0.8% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $754.8K | 740,000 | 0.8% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $512.4K | 49,800 | 0.5% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $443.5K | 44,000 | 0.4% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $411.9K | 18,139 | 0.4% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $397.5K | 74,307 | 0.4% |
| Celcuity Inc(CELC) | COM | 15102K100 | $327.3K | 25,000 | 0.3% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $290.9K | 16,400 | 0.3% |
| Nuvation BIO Inc -Cw27(NUVB/WS) | *W EXP 07/07/2027 | 67080N119 | $20.9K | 90,832 | 0.0% |